The Mosaic Company
MOS
$24.07
-1.67%
The Mosaic Company is one of the world's largest producers of concentrated phosphate and potash crop nutrients, operating phosphate rock mines in the United States and potash mines in Canada, alongside a substantial fertilizer distribution and blending business in Brazil through Mosaic Fertilizantes. As a vertically integrated agricultural inputs company, Mosaic occupies a critical position in global food security, competing with the likes of Nutrien and ICL Group while serving farmers across North and South America. The current investor narrative is dominated by a sharp divergence between geopolitical supply shocks and company-specific execution challenges: the closure of the Strait of Hormuz has stranded roughly a third of global fertilizer supply, creating a significant margin opportunity for North American producers with domestic inputs, yet Mosaic's most recent quarter delivered a surprising net loss of $257.6 million and negative free cash flow, raising questions about whether the company can capitalize on favorable pricing dynamics. Analysts are actively recalibrating their views, with Freedom Broker upgrading the stock from Sell to Buy in June 2026 and RBC Capital moving to Outperform in May 2026, even as Morgan Stanley, Barclays, and Wells Fargo maintain Equal Weight ratings, reflecting genuine uncertainty about the pace of recovery.…
MOS
The Mosaic Company
$24.07
Investment Opinion: Should I buy MOS Today?
The synthesized recommendation is Hold. Mosaic presents a classic value trap dilemma: the stock trades at a deep discount to book value (P/B 0.63) and sales (P/S 0.63), and analysts have a 'buy' consensus with an average target of $26.77, implying 9.4% upside. However, the company's recent Q1 2026 net loss of $257.6 million, negative free cash flow of -$489.3 million, and a 28.5% one-year decline suggest that the market is rightly skeptical about near-term execution. The risk/reward is balanced but not compelling enough to warrant a Buy until there is clear evidence of a turnaround.
Supporting evidence for a Hold includes the low valuation multiples, which provide a margin of safety, and the potential upside from the Hormuz supply disruption. Revenue grew 14.4% year-over-year in Q1 2026, and the company maintains a 3.67% dividend yield, attractive for income investors. However, profitability is the key issue: gross margin fell to 7.86%, operating margin is 8.71% on a trailing basis, and net margin is just 4.49%. The forward P/E of 15.65 is not cheap given the earnings uncertainty, and the PEG ratio of 0.068 is misleading due to the depressed earnings base. Analyst estimates for forward EPS of $2.82 imply a significant recovery, but the company must first demonstrate it can convert revenue growth into bottom-line results.
The biggest risks that could invalidate a more positive thesis are: (1) continued negative free cash flow leading to a dividend cut, (2) failure to capitalize on favorable fertilizer pricing due to operational issues, and (3) a sharp reversal in agricultural commodity prices. The rating would upgrade to Buy if the company reports positive EPS and free cash flow in the next quarter, or if the stock drops below $20 (near the 52-week low) with signs of stabilization. It would downgrade to Sell if Q2 2026 results show another large loss and negative cash flow, or if the dividend is cut. Relative to its own history and peers, MOS appears undervalued on asset-based metrics but fairly valued on earnings-based metrics, reflecting the market's uncertainty about its recovery prospects.
Sign up to view all
MOS 12-Month Price Forecast
Mosaic is at a crossroads: the stock is deeply undervalued on asset-based metrics, and the Hormuz supply disruption provides a potential catalyst for margin expansion, but the company's recent financial performance has been dismal, with a large net loss and negative cash flow. The analyst community is divided, with a 'buy' consensus but a wide target range of $17 to $35, reflecting high uncertainty. The base case (50% probability) assumes a slow recovery with the stock trading between $24 and $28, while the bull and bear cases each have 25% probability. I would upgrade to bullish if Q2 2026 results show a clear return to profitability and positive free cash flow, and downgrade to bearish if the company cuts its dividend or reports another large loss. Given the balanced risk/reward, a neutral stance is appropriate until there is more clarity on operational execution.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $26.77 and implied upside of +11.2% versus the current price.
Average Target
$26.77
0 analysts
Implied Upside
+11.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$17 - $35
Analyst target range
Bulls vs Bears: MOS Investment Factors
The bear case currently has stronger evidence, primarily due to the company's surprise Q1 2026 net loss of $257.6 million, negative free cash flow of -$489.3 million, and a 28.5% one-year decline that has massively underperformed the S&P 500. However, the bull case is not without merit: the stock trades below book value (P/B 0.63), the Hormuz closure has created a genuine supply shock that could benefit domestic producers, and analysts see 9.4% upside to their average target with recent upgrades. The single most important tension is whether Mosaic can convert the favorable pricing environment from the Hormuz disruption into actual margin expansion and positive cash flow, or whether operational missteps and cost inflation will continue to erode profitability. If Q2 2026 results show a return to positive earnings and free cash flow, the bull case could quickly gain traction; if losses persist, the stock may retest its 52-week low of $19.80.
Bullish
- Deep Value on Book and Sales: MOS trades at a price-to-book ratio of just 0.63 and price-to-sales of 0.63, meaning the market values the entire company at less than its book equity and less than one year of revenue. For a vertically integrated producer of essential agricultural inputs with $7.5 billion market cap, this is a historically depressed valuation that limits downside if asset values hold.
- Analyst Consensus Sees Upside: The average analyst target price is $26.77 versus the current $24.48, implying roughly 9.4% upside, with a high target of $35.00 (43% upside). The consensus recommendation is 'buy' with a mean rating of 2.45 across 18 analysts, and recent upgrades from Freedom Broker (Sell to Buy) and RBC Capital (Outperform) suggest sentiment is inflecting positively.
- Hormuz Closure Supply Shock: The closure of the Strait of Hormuz has stranded roughly one-third of global fertilizer supply, creating a significant margin opportunity for North American producers with domestic inputs. Mosaic's phosphate rock mines in the US and potash mines in Canada position it as a direct beneficiary of this supply disruption, which could drive realized prices and margins higher in coming quarters.
- Revenue Growth Despite Loss: Q1 2026 revenue grew 14.4% year-over-year to $2.998 billion, showing top-line resilience even as the company reported a net loss of $257.6 million. The loss was driven by $472.6 million in other expenses and a gross margin compression to 7.86%, but the revenue trajectory indicates underlying demand remains solid.
Bearish
- Surprise Quarterly Net Loss: Mosaic reported a Q1 2026 net loss of $257.6 million, or -$0.79 per diluted share, a stark reversal from $238.1 million net income in Q1 2025. The loss was driven by a collapse in gross margin to 7.86% from 18.63% a year earlier, and operating income swung to -$372.9 million, raising serious questions about cost control and operational execution.
- Negative Free Cash Flow: Trailing twelve-month free cash flow is -$489.3 million, meaning the company is burning cash despite revenue growth. With a payout ratio of 51.9% on a dividend yield of 3.67%, the sustainability of the dividend is questionable if cash flow does not inflect positively soon, potentially forcing a cut or increased borrowing.
- Severe Underperformance vs. Market: MOS has declined 28.46% over the past year while the S&P 500 gained 15.01%, resulting in a relative strength of -43.47%. Year-to-date, the stock is down 2.16% versus the S&P's 11.7% gain, and the max drawdown over the period is -44.84%, indicating persistent negative momentum and investor skepticism.
- High Leverage and Interest Burden: Debt-to-equity stands at 0.437, and interest expense in Q1 2026 was $65.3 million, up from $52.2 million a year earlier. With negative free cash flow and a net loss, servicing this debt consumes a significant portion of operating cash flow, limiting financial flexibility and increasing vulnerability to rising rates.
MOS Technical Analysis
Beta
0.83
0.83x market volatility
Max Drawdown
-44.8%
Largest decline past year
52-Week Range
$20-$37
Price range past year
Annual Return
-29.2%
Cumulative gain past year
| Period | MOS Return | S&P 500 |
|---|---|---|
| 1m | -1.4% | +1.0% |
| 3m | +13.3% | +5.4% |
| 6m | -8.1% | +17.8% |
| 1y | -29.2% | +16.5% |
| ytd | -3.8% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MOS Fundamental Analysis
Quarterly Revenue
$3.0B
2026-03
Revenue YoY Growth
+14.4%
YoY Comparison
Gross Margin
7.9%
Latest Quarter
Free Cash Flow
$-489300000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MOS Overvalued?
PE
14.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.8x
Enterprise Value Multiple
Investment Risk Disclosure
Mosaic faces significant financial and operational risks. The company reported a Q1 2026 net loss of $257.6 million and negative trailing twelve-month free cash flow of -$489.3 million, indicating it is burning cash even as revenue grew 14.4% year-over-year. Gross margin collapsed to 7.86% from 18.63% a year earlier, and operating income swung to -$372.9 million, highlighting severe cost pressures and potential inefficiencies in its phosphate and potash operations. With debt-to-equity at 0.437 and interest expense of $65.3 million in the quarter, the company's financial flexibility is constrained, and the 51.9% payout ratio on a 3.67% dividend yield may be unsustainable if cash flow does not improve. Additionally, Mosaic's Brazilian distribution business exposes it to currency and political risks in that region, while its revenue is concentrated in agricultural inputs, making it vulnerable to commodity price swings and farmer demand cycles.
Market and competitive risks are also pronounced. The stock has a beta of 0.831, suggesting lower volatility than the market, but it has still suffered a max drawdown of -44.84% over the past year and underperformed the S&P 500 by 43.47 percentage points. Valuation compression risk is real: while P/B of 0.63 and P/S of 0.63 appear cheap, the forward P/E of 15.65 is not low for a company with negative earnings, and if the anticipated recovery does not materialize, the stock could de-rate further. Competitive pressures from Nutrien and ICL Group, as well as potential new supply from other regions once the Hormuz disruption resolves, could limit pricing power. Regulatory risks, including environmental regulations on phosphate mining and potential changes to Brazilian agricultural policy, add another layer of uncertainty. The recent news about the Hormuz closure boosting fertilizer stocks is a double-edged sword: while it creates a near-term opportunity, it also introduces geopolitical volatility that could reverse quickly.
In a worst-case scenario, Mosaic's operational issues persist, the Hormuz supply disruption resolves faster than expected, and global fertilizer prices normalize, leading to further margin compression and cash burn. The company could be forced to cut its dividend, further eroding investor confidence, and the stock could retest its 52-week low of $19.80, representing a 19.1% decline from the current price of $24.48. If analyst bear-case targets are met, the low target of $17.00 implies a 30.6% downside. A more severe scenario, such as a global recession reducing agricultural demand or a major operational failure at a key mine, could push the stock below $17, approaching the lower end of its historical trading range. Investors could lose 20-30% from current levels in this adverse scenario, with the possibility of a dividend cut exacerbating total return losses.
FAQ
The most severe risk is financial: Mosaic is burning cash with negative free cash flow of -$489.3 million and reported a Q1 2026 net loss of $257.6 million, which could force a dividend cut (payout ratio 51.9%) and further erode investor confidence. Operational risks include margin compression (gross margin fell to 7.86%) and potential mine disruptions. Competitive risks arise from global fertilizer supply normalizing if the Hormuz closure resolves, which would pressure prices. Macro risks include a global recession reducing agricultural demand and a strong dollar hurting Brazilian operations. Additionally, the stock has a beta of 0.831 but has still suffered a max drawdown of -44.84%, showing it is not immune to market downturns. Ranked by severity: financial, operational, competitive, macro.
Our 12-month forecast for MOS has three scenarios. The base case (50% probability) targets $24-28, assuming a slow recovery with modest revenue growth and breakeven cash flow. The bull case (25% probability) targets $30-35, driven by successful capitalization on the Hormuz supply disruption, margin expansion, and positive free cash flow. The bear case (25% probability) targets $17-20, assuming continued losses, a dividend cut, and a resolution of the supply disruption. The most likely scenario is the base case, with the key assumption that Mosaic avoids another large quarterly loss and shows progress toward profitability. Analyst consensus average target is $26.77, which aligns with the upper end of our base case.
MOS appears undervalued on asset-based metrics but fairly valued on earnings-based metrics. The price-to-book ratio of 0.63 means the stock trades at a 37% discount to its book equity, and the price-to-sales ratio of 0.63 is also low. However, the trailing P/E of 14.17 and forward P/E of 15.65 are not particularly cheap for a company with negative earnings and cash flow. The PEG ratio of 0.068 is misleading because it uses a depressed earnings base. Compared to peers like Nutrien, MOS may be undervalued on a P/B basis, but the market is pricing in significant uncertainty about its ability to generate consistent profits. The valuation implies that investors expect a recovery, but not a rapid one.
MOS presents a high-risk, high-reward opportunity that is not suitable for all investors. The stock trades at a deep discount to book value (P/B 0.63) and has a consensus analyst target of $26.77, implying 9.4% upside, with a high target of $35.00. However, the company reported a Q1 2026 net loss of $257.6 million and negative free cash flow of -$489.3 million, and the stock has fallen 28.5% over the past year. For value investors with a long time horizon and tolerance for volatility, the low valuation and potential Hormuz-related tailwind could make it a contrarian buy, but only if they believe management can execute a turnaround. For most investors, waiting for evidence of positive earnings and cash flow before buying would be prudent.
MOS is more suitable for long-term investment than short-term trading, but only for patient investors who can tolerate volatility. The company is in a turnaround phase, and the thesis depends on operational improvements and favorable fertilizer prices materializing over several quarters. The beta of 0.831 suggests lower volatility than the market, but the stock has a max drawdown of -44.84% and a 28.5% one-year decline, indicating significant risk. The 3.67% dividend yield provides some income, but the payout ratio of 51.9% and negative free cash flow make it uncertain. A suggested minimum holding period is 18-24 months to allow for a full recovery cycle. Short-term traders might find opportunities around earnings announcements, but the stock is not ideal for quick trades due to its fundamental uncertainties.